In vivo characterization and quantification of neurofibrillary tau PET radioligand 18F-MK-6240 in humans from Alzheimer disease dementia to young controls TJ Betthauser, KA Cody, MD Zammit, D Murali, AK Converse, TE Barnhart, ... Journal of Nuclear Medicine 60 (1), 93-99, 2019 | 195 | 2019 |
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring NJ Ashton, S Janelidze, N Mattsson-Carlgren, AP Binette, O Strandberg, ... Nature medicine 28 (12), 2555-2562, 2022 | 129 | 2022 |
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age TJ Betthauser, RL Koscik, EM Jonaitis, SL Allison, KA Cody, CM Erickson, ... Brain 143 (1), 320-335, 2020 | 129 | 2020 |
Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers N Mattsson-Carlgren, G Salvadó, NJ Ashton, P Tideman, E Stomrud, ... JAMA neurology 80 (4), 360-369, 2023 | 72 | 2023 |
Amyloid duration is associated with preclinical cognitive decline and tau PET RL Koscik, TJ Betthauser, EM Jonaitis, SL Allison, LR Clark, BP Hermann, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 71 | 2020 |
Assessment of vascular stiffness in the internal carotid artery proximal to the carotid canal in Alzheimer’s disease using pulse wave velocity from low rank reconstructed 4D … LA Rivera-Rivera, KA Cody, L Eisenmenger, P Cary, HA Rowley, ... Journal of Cerebral Blood Flow & Metabolism 41 (2), 298-311, 2021 | 44 | 2021 |
Divergent cortical tau positron emission tomography patterns among patients with preclinical Alzheimer disease CB Young, JR Winer, K Younes, KA Cody, TJ Betthauser, SC Johnson, ... JAMA neurology 79 (6), 592-603, 2022 | 35 | 2022 |
Amyloid accumulation in Down syndrome measured with amyloid load MD Zammit, CM Laymon, TJ Betthauser, KA Cody, DL Tudorascu, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 31 | 2020 |
Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome KA Cody, B Piro-Gambetti, MD Zammit, BT Christian, BL Handen, ... Neurobiology of aging 93, 44-51, 2020 | 27 | 2020 |
Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation PJ Lao, BL Handen, TJ Betthauser, KA Cody, AD Cohen, DL Tudorascu, ... Brain imaging and behavior 13, 345-353, 2019 | 25 | 2019 |
Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease EM Jonaitis, S Janelidze, KA Cody, R Langhough, L Du, NA Chin, ... Brain Communications 5 (2), fcad057, 2023 | 21 | 2023 |
Intracranial vascular flow oscillations in Alzheimer’s disease from 4D flow MRI LA Rivera-Rivera, KA Cody, D Rutkowski, P Cary, L Eisenmenger, ... NeuroImage: Clinical 28, 102379, 2020 | 20 | 2020 |
Leisure Activity, Brain β‐amyloid, and Episodic Memory in Adults with Down Syndrome I Mihaila, BL Handen, BT Christian, PJ Lao, KA Cody, WE Klunk, ... Developmental neurobiology 79 (7), 738-749, 2019 | 18 | 2019 |
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology NJ Ashton, WS Brum, G Di Molfetta, AL Benedet, B Arslan, E Jonaitis, ... JAMA neurology, 2024 | 15 | 2024 |
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A … G Salvadó, V Larsson, KA Cody, NC Cullen, EM Jonaitis, E Stomrud, ... Alzheimer's & Dementia 19 (7), 2943-2955, 2023 | 14 | 2023 |
Normative cerebral hemodynamics in middle-aged and older adults using 4D flow MRI: initial analysis of vascular aging GS Roberts, A Peret, EM Jonaitis, RL Koscik, CA Hoffman, ... Radiology 307 (3), e222685, 2023 | 12 | 2023 |
White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study A Bazydlo, M Zammit, M Wu, D Dean, S Johnson, D Tudorascu, A Cohen, ... Journal of neurodevelopmental disorders 13, 1-8, 2021 | 11 | 2021 |
Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer’s disease pathology NJ Ashton, WS Brum, G Di Molfetta, AL Benedet, B Arslan, E Jonatis, ... medRxiv, 2023 | 7 | 2023 |
Prescription medications and co-morbidities in late middle-age are associated with greater cognitive declines: Results from WRAP L Du, RL Koscik, NA Chin, LC Bratzke, K Cody, CM Erickson, E Jonaitis, ... Frontiers in Aging 2, 759695, 2022 | 6 | 2022 |
P3‐325: AMYLOID‐β ASSOCIATIONS WITH WHITE MATTER IN DOWN SYNDROME ASSESSED USING TRACT‐BASED SPATIAL STATISTICS (TBSS) AND 11C‐PIB POSITRON EMISSION TOMOGRAPHY A Patrick, M Wu, PJ Lao, DC Dean III, MD Zammit, SC Johnson, ... Alzheimer's & Dementia 15, P1063-P1063, 2019 | 6 | 2019 |